Sentence examples for baseline prognosis from inspiring English sources

BSI can also be of value in clinical trials as an inclusion criterion so that baseline prognosis in treatment and placebo groups can be matched.

With one such approach TBI patients' outcomes are defined taking account their baseline prognosis, instead of using the usual Glasgow Outcome Scale dichotomized in favourable or unfavourable.

The sliding dichotomy approach dichotomizes the GOS into a binary measure, but the point of dichotomy is tailored to each individual patient's baseline prognosis [ 11].

Second, about two-thirds of the patients enrolled into the ATAC study were node negative, and it has been suggested that their relatively good baseline prognosis makes it harder to demonstrate a significant absolute mortality difference.

As there was no significant difference in the treatment effect of the randomised agents in the EGF20001 trial, the baseline prognosis of patients would not have been modified by the treatment assignment.

In contrast, the basal-like subtype is of particular clinical focus due to its high frequency, lack of effective targeted therapies, poor baseline prognosis, and tendency to affect younger women [ 3].

Channeling occurs when drug therapies with similar indications are preferentially prescribed to groups of patients with varying baseline prognoses.

It uses data from national databases and other sources to make estimates of a patient's baseline prognoses.

In this study, subjects served as their own controls, minimizing the potential for differences in baseline prognoses between treatment sequences; however, the effect of treatment period on outcome measures cannot be systematically assessed in nonrandomized crossover study designs.

Furthermore, today we know that breast cancer subtypes carry different sets of mutations and are linked with different baseline prognoses – these differences can be easily detected using the G-2-O analysis platform which enables one to investigate the effect on prognosis in each of the molecular subtypes separately.

Over the years, global gene expression analyses have identified at least four intrinsic subtypes of breast cancer (Luminal A, Luminal B, HER2-enriched, and Basal-like) and a normal-like group with significant differences in terms of their risk factors, incidence, baseline prognoses and responses to systemic therapies [ 1– 4].